These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5633311)

  • 21. [Basedow's disease].
    Torizuka K; Mori T; Morita T; Konishi J; Iio A
    Naika; 1967 Nov; 20(5):865-76. PubMed ID: 4877778
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of 131 I treatment of diffuse toxic thyroids.
    Rosenthall L
    J Can Assoc Radiol; 1972 Sep; 23(3):171-5. PubMed ID: 4678167
    [No Abstract]   [Full Text] [Related]  

  • 23. [Toxic adenoma of the thyroid (study of 120 cases)].
    Papalia D; Vigneri R; Motta L
    Folia Endocrinol; 1968 Aug; 21(4):501-28. PubMed ID: 5757117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of I 131 therapy on SH-group serum levels in patients with toxic goiter].
    Semenov VD
    Med Radiol (Mosk); 1970 Jun; 15(6):58-62. PubMed ID: 5468341
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of hyperthyroidism in Grave's disease with low doses of radioactive iodine].
    Wils JA; Kloppenborg PW
    Ned Tijdschr Geneeskd; 1971 Apr; 115(15):657-62. PubMed ID: 5108052
    [No Abstract]   [Full Text] [Related]  

  • 26. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The development of adenoma and atypical adenoma following I-131 treatment of thyroid gland diseases].
    Zukschwerdt L; Bay V; Gusek W
    Zentralbl Chir; 1967; 92(26a Pt 1):1319-24. PubMed ID: 5631684
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interrelationships between the blood hormonal iodine and radioactivity of the thyroid tissue in diffuse toxic goiter].
    Bykhovskaia AM
    Probl Endokrinol (Mosk); 1967; 13(6):20-3. PubMed ID: 4186890
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood levels of parathyroid hormone, calcitonin, calcium and magnesium in patients with diffuse toxic goiter].
    Mosin VI; Borodina LV
    Ter Arkh; 1981; 53(11):112-4. PubMed ID: 6896101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electrolyte metabolism in patients with toxic goiter and its dynamics in radioiodine therapy].
    Trusov VV; Pevchikh VV
    Probl Endokrinol (Mosk); 1968; 14(2):39-42. PubMed ID: 5757162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypothyroidism due to therapy of Basedow's disease with radioiodine].
    Giustina G; Valentini F; Cantalamessa L; Reschini E; Lodeserto A
    Folia Endocrinol; 1966 Feb; 19(1):34-47. PubMed ID: 5953703
    [No Abstract]   [Full Text] [Related]  

  • 32. [The level of lecithin, cholesterol and its fractions in the blood in diffuse toxic goiter].
    Slukhaĭ IuF
    Sov Med; 1967 Oct; 30(10):45-9. PubMed ID: 5632742
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
    Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
    J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications for surgical treatment of diffuse toxic goiter].
    Vetshev PS; Balabolkin MI; Petunina NA; Trukhina LV
    Khirurgiia (Mosk); 2000; (8):4-7. PubMed ID: 10996996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of diffuse toxic goiter with 131-I.
    Dworkin HJ
    Semin Nucl Med; 1971 Oct; 1(4):399-410. PubMed ID: 4940743
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical value of determining specific serum glycoproteids in patients with goiter].
    Kuz'mak NI
    Vrach Delo; 1971 Aug; 8():78-80. PubMed ID: 5172298
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormonal activity and morphological changes in the thyroid gland in toxic goiter].
    Krivitskiĭ DI
    Vestn Khir Im I I Grek; 1983 Oct; 131(10):6-9. PubMed ID: 6197802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of nodular goiter.
    Ahuja MM; Kumar V; Malhotra KK; Prakash A; Kapur MM
    J Assoc Physicians India; 1968 Oct; 16(10):699-707. PubMed ID: 5715495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of reserpine on blood lipid and urine catecholamine levels in patients with diffuse toxic goiter].
    Baranov VG; Zaripova ZKh; Slobodskoĭ VR; Ugoleva SV
    Ter Arkh; 1971 Jul; 43(7):98-102. PubMed ID: 5172576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.